Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.21
0.13 (4.22%)
At close: Aug 20, 2025, 3:59 PM
3.25
1.24%
After-hours: Aug 20, 2025, 04:43 PM EDT

Cumberland Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
16.09M 15.11M 17.96M 17.46M 17.34M 18.55M 18.32M 18.51M 18.25M 16.39M 19.76M 19.54M 18.22M 17.27M 27.04M 25.84M 25.67M 24.92M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
12.38M 12.68M 13.79M 14.66M 14.86M 15.98M 15.5M 10.86M 9.3M 10.08M 10.05M 9.92M 12.91M 13.77M 12.47M 12.78M 13.37M 13.74M
Receivables
10.32M 10.49M 11.7M 11.31M 11.62M 10.65M 9.76M 12.62M 12.22M 14.53M 13.16M 15.23M 13.28M 14.64M 6.88M 9.85M 9.15M 12.55M
Inventory
3.22M 4.1M 4M 4.51M 4.3M 4.33M 4.61M 8.67M 10.93M 10.18M 9.4M 10.65M 9.42M 9.88M 8.43M 10.26M 10.1M 10.01M
Other Current Assets
1.58M 2.18M 2.79M 1.95M 2.32M 2.68M 3.03M 1.97M 2.28M 2.72M 3.08M 3.74M 2.84M 3.56M 3.34M 1.26M 1.76M 1.9M
Total Current Assets
31.21M 31.88M 36.45M 35.24M 35.58M 36.21M 35.71M 41.77M 43.67M 43.81M 45.87M 49.01M 43.75M 45.34M 45.69M 47.22M 46.68M 49.38M
Property-Plant & Equipment
7.42M 7.48M 6.45M 6.52M 6.7M 6.89M 7.04M 7.09M 7.22M 5.27M 5.5M 1.5M 950.59K 1.17M 1.47M 1.78M 2.03M 2.32M
Goodwill & Intangibles
16.9M 17.9M 18.89M 20.33M 21.37M 22.44M 23.52M 28.04M 29.18M 30.3M 31.5M 30.98M 34.91M 36.41M 24.84M 25.8M 26.77M 27.91M
Total Long-Term Assets
36.7M 38.06M 39.13M 41.51M 42.94M 45.3M 46.06M 45.98M 45.7M 45.66M 47.05M 42.41M 48.77M 51.36M 38.77M 40.36M 42.17M 43.97M
Total Assets
67.91M 69.94M 75.58M 76.75M 78.52M 81.51M 81.78M 87.75M 89.38M 89.47M 92.93M 91.42M 92.52M 96.7M 84.46M 87.57M 88.85M 93.35M
Account Payables
13.45M 13.93M 13.91M 12.06M 12.51M 13.08M 14.04M 10.82M 10.91M 11.22M 10.82M 11.51M 10.59M 11.45M 9.64M 9.23M 8.96M 10.47M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
386.08K n/a 5.1M 5.99M 376.78K 362.24K n/a 334.29K n/a 158.37K n/a 229.6K 512.32K 766.49K n/a 1.09M 1.07M 1.04M
Other Current Liabilities
10.14M 11.22M 10.18M 12.65M 11.49M 12.63M 12.4M 15.84M 15.73M 14.17M 16.15M 13.34M 12.64M 11.58M 7.33M 6.52M 7.55M 10.3M
Total Current Liabilities
23.97M 25.52M 31.62M 31.09M 24.76M 26.43M 27.98M 27.33M 26.96M 25.71M 28.58M 25.95M 24.25M 24.56M 19.28M 17.95M 18.65M 22.85M
Long-Term Debt
5.24M 5.24M 10.18M 10.1M 16.09M 16.08M 12.78M 18.31M 13.15M 20.62M 16.2M 17.7M 19M 20.02M 15M 15.23M 14.51M 15.79M
Other Long-Term Liabilities
6.3M 6.01M 6.3M 6.09M 6.54M 6.61M 6.45M 1.07M 6.95M 2.54M 7.59M 9.28M 10.06M 11.3M 7.49M 7.52M 7.37M 7.04M
Total Long-Term Liabilities
16.26M 16.08M 21.42M 21.19M 27.73M 27.89M 24.53M 24.77M 25.58M 27.71M 28.37M 26.98M 29.06M 31.35M 22.58M 22.98M 22.4M 23.62M
Total Liabilities
40.23M 41.6M 53.04M 52.28M 52.49M 54.32M 52.52M 52.1M 52.54M 53.42M 56.95M 52.93M 53.31M 55.9M 41.86M 40.92M 41.04M 46.47M
Total Debt
10.34M 10.44M 20.57M 21.48M 21.57M 21.65M 18.43M 18.65M 18.95M 20.78M 20.96M 17.93M 19.51M 20.79M 16.06M 16.32M 15.58M 16.83M
Common Stock
51.44M 51.37M 46.82M 46.84M 46.87M 46.92M 47.09M 47.19M 47.3M 47.38M 47.47M 47.53M 47.82M 48.05M 48.45M 48.61M 48.69M 48.98M
Retained Earnings
-23.45M -22.71M -23.97M -22.06M -20.52M -19.43M -17.49M -11.19M -10.14M -11.02M -11.21M -8.77M -8.36M -7.02M -5.64M -1.79M -735.63K -1.96M
Comprehensive Income
n/a n/a n/a n/a 0.00 -0.00 n/a -0.00 -0.00 0.00 n/a -0.00 -0.00 -0.00 0.00 -0.00 0.00 -0.00
Shareholders Equity
27.99M 28.66M 22.85M 24.78M 26.35M 27.49M 29.6M 35.99M 37.16M 36.36M 36.27M 38.76M 39.46M 41.02M 42.81M 46.82M 47.95M 47.02M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a